Bayer invests 130 million EUR in new production facility for innovative parenteral products

Bayer has added a brand new manufacturing facility to its global supply chain network. The new production plant was inaugurated today at the company's global pharmaceutical headquarters in Berlin, Germany. The facility features state-of-the-art technology, innovative production, and automated processes.

from Breaking World Pharma News https://ift.tt/l0gqMa8